<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0138-6557</journal-id>
<journal-title><![CDATA[Revista Cubana de Medicina Militar]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. cuban. med. mil.]]></abbrev-journal-title>
<issn>0138-6557</issn>
<publisher>
<publisher-name><![CDATA[Centro Nacional de Información de Ciencias MédicasEditorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0138-65572023000200015</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Caracterización clínica de pacientes con esclerosis múltiple]]></article-title>
<article-title xml:lang="en"><![CDATA[Clinical characterization of patients with multiple sclerosis]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lotti-Mesa]]></surname>
<given-names><![CDATA[Roberto Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gutiérrez-Gacel]]></surname>
<given-names><![CDATA[Liudmila]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Moreno-Cubela]]></surname>
<given-names><![CDATA[Fidel Jesús]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de Granma Hospital Clínico Quirúrgico Docente &#8220;Celia Sánchez Manduley&#8221; ]]></institution>
<addr-line><![CDATA[Manzanillo Granma]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Ciencias Médicas de Granma Policlínico Universitario &#8220;Ángel Alfonso Ortiz Vázquez&#8221; ]]></institution>
<addr-line><![CDATA[Manzanillo Granma]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Ciencias Médicas de Granma Facultad de Ciencias Médicas de Manzanillo &#8220;Celia Sánchez Manduley&#8221; ]]></institution>
<addr-line><![CDATA[ Granma]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2023</year>
</pub-date>
<volume>52</volume>
<numero>2</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0138-65572023000200015&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0138-65572023000200015&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0138-65572023000200015&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: La esclerosis múltiple es una enfermedad autoinmune, inflamatoria, desmielinizante, crónica, del sistema nervioso central. Supone la primera causa de discapacidad no traumática en adultos jóvenes; afecta de forma significativa la calidad de vida de los pacientes, con alteraciones físicas, sociales y emocionales.  Objetivo: Caracterizar desde el punto de vista clínico, a pacientes con diagnóstico de esclerosis múltiple.  Método: Se realizó un estudio descriptivo transversal en una serie de casos de 40 pacientes, según las variables edad, sexo, comorbilidad, síntomas iniciales, formas clínicas y grado de discapacidad. Se realizó un análisis de frecuencias.  Resultados: Predominaron los pacientes con edades comprendidas entre 30 y 39 años (57,5 %). Los pacientes del sexo femenino representaron el 58,8 % de los casos estudiados y el 85,5% presentó manifestaciones motoras, como síntomas iniciales de la enfermedad. La forma clínica de esclerosis múltiple más frecuente fue la recurrente remitente y el grado de discapacidad mínima.  Conclusiones: Las manifestaciones motoras son los síntomas iniciales más frecuentes, así como la forma clínica recurrente remitente y el grado de discapacidad mínima. Los pacientes son fundamentalmente del sexo femenino, en la cuarta década de la vida.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction: Multiple sclerosis is a chronic, inflammatory, demyelinating, autoimmune disease of the central nervous system. It is the first cause of non-traumatic disability in young adults, significantly affecting the quality of life, with physical, social and emotional alterations.  Objective:  To characterize from the clinical point of view, patients diagnosed with multiple sclerosis.  Method:  A descriptive and cross-sectional observational study was carried out in a case series of 40 patients, with variables age, sex, comorbidity, initial symptoms, clinical forms and degree of disability. A frequency analysis was carried out.  Results:  Patients aged between 30 and 39 years (57.5%) predominated. Female patients represented 58.8% of the cases studied and 85.5% presented motor manifestations, as initial symptoms of the disease. Motor symptoms were predominant during the onset of the disease. The most frequent clinical form of multiple sclerosis was relapsing-remitting and the degree of minimal disability.  Conclusions:  Motor manifestations are the most frequent initial symptoms, as well as the relapsing-remitting clinical form and the minimum degree of disability. The patients are fundamentally female, in the fourth decade of life.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[esclerosis múltiple]]></kwd>
<kwd lng="es"><![CDATA[esclerosis múltiple recurrente-remitente]]></kwd>
<kwd lng="es"><![CDATA[discapacidad]]></kwd>
<kwd lng="es"><![CDATA[trastornos motores]]></kwd>
<kwd lng="en"><![CDATA[multiple sclerosis, relapsing-remitting multiple sclerosis, disability]]></kwd>
<kwd lng="en"><![CDATA[motor disorders]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arteaga-Noriega]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Zapata-Berruecos]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Castro-Álvarez]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Benjumea-Bedoya]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Segura-Cardona]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[González Gómez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores clínicos y radiológicos relacionados con la progresión de la discapacidad en esclerosis múltiple]]></article-title>
<source><![CDATA[Rev. Ecuat. Neurol]]></source>
<year>2020</year>
<volume>29</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>62-71</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ropper]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
<name>
<surname><![CDATA[Samuels]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Klein]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Esclerosis múltiple y otras enfermedades inflamatorias]]></article-title>
<collab>Adams y Victor</collab>
<source><![CDATA[Principios de neurología]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Colombia ]]></publisher-loc>
<publisher-name><![CDATA[Mcgraw-Hill]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bravo-González]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez-Roldan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Esclerosis múltiple, pérdida de funcionalidad y género]]></article-title>
<source><![CDATA[Gac Sanit]]></source>
<year>2019</year>
<volume>33</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>1-8</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<collab>MS International Federation</collab>
<source><![CDATA[Atlas of MS. MS International Federation]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Estrada González]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Casos presentados y discutidos en las sesiones de Neuropatología]]></article-title>
<source><![CDATA[Revista Cubana de Cirugía]]></source>
<year>1965</year>
<volume>4</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>201-24</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cabrera-Gómez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Manero-Alfert]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Algunas consideraciones sobre esclerosis múltiple en Latinoamérica. Primera estadística presentada en Cuba. Estudio comparativo]]></article-title>
<source><![CDATA[Rev Cub Med]]></source>
<year>2020</year>
<volume>14</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vázquez-Gómez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Hidalgo-Mesa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Beltrán-González]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Broche-Pérez]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Mederos-Herrera]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efectividad de una estrategia para el seguimiento multidisciplinario de pacientes con esclerosis múltiple]]></article-title>
<source><![CDATA[EDUMECENTRO]]></source>
<year>2021</year>
<volume>13</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vázquez-Gómez]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Hidalgo Mesa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Beltrán González]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
<name>
<surname><![CDATA[Broche-Pérez]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Mederos-Herrera]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Perfil epidemiológico, clínico e imagenológico de la esclerosis múltiple]]></article-title>
<source><![CDATA[Medisur]]></source>
<year>2021</year>
<volume>19</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>948-58</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández Fernández]]></surname>
<given-names><![CDATA[Ó]]></given-names>
</name>
<name>
<surname><![CDATA[Saiz Hinarejos]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedades desmielinizantes del sistema nervioso central]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Rozman]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cardellac López]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[Farreras-Rozman Medicina Interna]]></source>
<year>2020</year>
<edition>19</edition>
<page-range>1394-9</page-range><publisher-loc><![CDATA[España, Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier España]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zarranz Imirizalddu]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Neurología 6ta ed]]></source>
<year>2018</year>
<publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier España]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández-Valero]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera-Gómez]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Valenzuela]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características clínicas de la esclerosis múltiple en el Occidente de Cuba. Comparación con otras dos regiones del país]]></article-title>
<source><![CDATA[Rev Neurol]]></source>
<year>2004</year>
<volume>38</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>818-23</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Correa E]]></surname>
<given-names><![CDATA[Ortiz M]]></given-names>
</name>
<name>
<surname><![CDATA[Guillen]]></surname>
<given-names><![CDATA[Toral AM]]></given-names>
</name>
<name>
<surname><![CDATA[Terán E]]></surname>
<given-names><![CDATA[Ortaneda D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of multiple sclerosis in Cuenca, Ecuador]]></article-title>
<source><![CDATA[MSJ]]></source>
<year>2019</year>
<volume>24</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>738-80</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rojas Huerto]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Alva Díaz]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Montalván Ayala]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cambios clínicos de la esclerosis múltiple según modificación de los criterios de McDonald. Hospital Almenara, 2001-2015]]></article-title>
<source><![CDATA[An Fac Med]]></source>
<year>2019</year>
<volume>80</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>34-8</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vázquez-Céspedes]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández-Morales]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Valverde-Espinosa]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Moraga-López]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Carazo-Céspedes]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Perfil demográfico y clínico de la esclerosis múltiple en Costa Rica: revisión de la casuística nacional a diciembre de 2017]]></article-title>
<source><![CDATA[Neurol Arg]]></source>
<year>2021</year>
<volume>13</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>69-77</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delgado-Cabrera]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Galán-Palma]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández-Mogollón]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características clínico-epidemiológicas de pacientes con esclerosis múltiple en dos hospitales de alta complejidad]]></article-title>
<source><![CDATA[Rev.CM HNAAA]]></source>
<year>2021</year>
<volume>14</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>35-9</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Magyari]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Soelberg Sorensen]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comorbidity in Multiple Sclerosis]]></article-title>
<source><![CDATA[Frontiers in Neurology]]></source>
<year>2020</year>
<volume>11</volume>
<numero>851</numero>
<issue>851</issue>
<page-range>1-9</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cárdenas-Robledo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Otero-Romero]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Passarell-Bacardit]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Carbonell-Mirabent]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sastre-Garriga]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Montalbán]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multiple sclerosis is associated with higher comorbidity and health care resource use: A population-based, case-control study in a western Mediterranean region]]></article-title>
<source><![CDATA[Eur J.Neurol]]></source>
<year>2021</year>
<volume>28</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1-11</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cárdenas-Robledo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Otero-Romero]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Montalbán]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Tintoré]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia e impacto de las comorbilidades en pacientes con esclerosis múltiple]]></article-title>
<source><![CDATA[Rev Neurol]]></source>
<year>2020</year>
<volume>71</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>151-8</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vázquez Gómez]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Hidalgo Mesa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Broche Pérez]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Valdés Morales]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Tejeda Castañeda]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización epidemiológica, clínica e imagenológica de pacientes con esclerosis múltiple]]></article-title>
<source><![CDATA[Medicen Electrón]]></source>
<year>2021</year>
<volume>25</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>423-46</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García-Estévez]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Fraga-González]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos-Pacho]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[López-Díaz]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Pardo-Parrado]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Prieto]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de la esclerosis múltiple en la ciudad de Ourense, Galicia, noroeste de la Península Ibérica]]></article-title>
<source><![CDATA[Rev Neurol]]></source>
<year>2020</year>
<volume>71</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>19-25</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
